[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100275322":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":44,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":10,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Humanity and Health Research Centre","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"CHB Group",null,"Patients with chronic hepatitis B",{"label":13,"type":10,"description":14,"interventionNames":10},"CHB\u002FNAFLD Group","Patients with chronic hepatitis B and comorbid nonalcoholic fatty liver disease",{"label":16,"type":10,"description":17,"interventionNames":10},"NAFLD Group","Patients with nonalcoholic fatty liver disease",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"George Lau, MD","CONTACT","+852 2861 3777","gkklau@netvigator.com",[25],{"facility":26,"status":27,"city":28,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Humanity and Health GI and Liver Centre","RECRUITING","Hong Kong","00852","China","CN",{"type":33,"coordinates":34},"Point",[35,36],114.17469,22.27832,{"lat":36,"lon":35},[39,42],{"name":40,"role":21,"phone":41,"phoneExt":10,"email":23},"George KK Lau, MD","(852)28613777",{"name":40,"role":43,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100275322","follow-up-of-chronic-hepatitis-b-patients-with-comorbid-nonalcoholic-fatty-liver-disease-100275322",false,"NCT02863757","Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease","Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)","Inclusion Criteria:\n\n* Liver biopsy proved CHB and\u002For NAFLD at baseline;\n* Chinese\n* Follow-up duration\\>12 months\n\nExclusion Criteria:\n\n* Other liver diseases;\n* Secondary causes of hepatic steatosis;\n* Alcohol abuse;\n* Liver cirrhosis, cirrhosis related complications or HCC at baseline;\n* Malignancy;\n* History of liver transplantation","ALL",{"count":55,"type":56},1500,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to determine the disease progression in CHB\u002FNAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).",[60,61],"Chronic Hepatitis B","Nonalcoholic Fatty Liver Disease","2025-03-20",{"date":64,"type":65},"2025-03-24","ACTUAL",{"date":67,"type":65},"2016-08-01",{"date":69,"type":56},"2026-12",{"name":5,"class":6},1]